Coronavirus Update With Rochelle Walensky
Coronavirus Update With Rochelle Walensky
Rochelle P. Walensky, MD, MPH of Harvard Medical School and Massachusetts General Hospital returns to JAMA's COVID-19 Q&A to provide an update on developments in the pandemic. She is a signatory of the recent John Snow Memorandum emphasizing the importance of public health interventions to managing spread of COVID-19. See https://www.johnsnowmemo.com/. Recorded October 22, 2020.• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire. Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
Topics discussed in this interview:
0:00 Introduction
0:23 Infectious Diseases Society of America (IDSA) Week
1:35 Herd Immunity and the Great Barrington Declaration
5:30 Hurdles to herd immunity by natural infection
6:58 Young people and COVID-19
8:00 Herd immunity and the economy
9:10 Excess deaths and coming months
12:19 Treatments update
15:50 Remdesivir and monoclonal antibodies
18:41 Costs of treatments, infrastructure and disparities
20:34 Vaccines
24:45 Hurdles to vaccine distribution
28:45 Geographic distribution of vaccines
30:55 The CDC
33:38 The biggest surprises
35:50 Communication in public health
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwork
Follow the #JAMANetwork
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #Pandemic #COVID19 #SARSCoV2
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.